Pricing Log in Create free account

Minerva Neurosciences, Inc (NERV) vs Voyager Therapeutics, Inc. (VYGR)

Minerva Neurosciences, Inc and Voyager Therapeutics, Inc. are both Biotechnology companies. Minerva Neurosciences, Inc and Voyager Therapeutics, Inc. are of similar size ($109.8M and $106.0M). Minerva Neurosciences, Inc has the higher net margin (0.00% vs −416.3%) and the higher return on invested capital (0.00% vs −249.6%). Across the 12 metrics below, Minerva Neurosciences, Inc leads on 7 and Voyager Therapeutics, Inc. on 5.

Valuation

Metric NERV VYGR Biotechnology median
P/E n/m n/m 10.60
P/S n/m 4.68 9.40
P/B n/m 0.87 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 0.42 9.02
Earnings yield (1,172.31%) (91.58%) (32.88%)
Free cash flow yield (23.31%) (93.67%) (23.13%)

Profitability

Metric NERV VYGR Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (450.12%) 0.00%
Net margin 0.00% (416.32%) 0.00%
Free cash flow margin 0.00% (434.88%) 0.00%
Return on equity 322.05% (58.90%) (51.96%)
Return on assets (629.71%) (44.92%) (46.06%)
Return on invested capital 0.00% (249.55%) 0.00%

Growth

Metric NERV VYGR Biotechnology median
Revenue growth (TTM) — (19.82%) 6.76%
EPS growth (last fiscal year) (18,347.37%) (80.53%) 29.88%
Revenue growth, 5-year CAGR — (25.09%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NERV VYGR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 20.14 6.81 4.97
Net debt to EBITDA 5.46 1.50 1.01

Dividend

Metric NERV VYGR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NERV VYGR Biotechnology median
Market cap 109.82m 105.99m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack